B cells are known to promote allergy through antigen presentation and class‐switching to IgE, whereas under certain conditions, tumor‐infiltrating B cells can be associated with improved patient survival in cancer.79, 84 In contrast, Breg‐associated immune tolerance can lead to control of allergy or tumor progression in cancer.79 This evidence concerns the gene IGHE and neoplasm.